US Broker Ratings

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unpacking a 165% Potential Upside in the Biotech Arena

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its compelling potential upside of 165.03%, as analysts set an average target price of $24.25, significantly..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Unlocking a 71% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc. (NASDAQ: PLSE), a leading player in the bioelectric medicine sector, is capturing the attention of investors with its promising technology and significant upside..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 16.84% Potential Upside in Medical Devices

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leading name in the healthcare sector, is capturing the attention of investors with its innovative approach to medical devices,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Analysts Predict 32.88% Upside for Healthcare Innovator

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Eagle, Idaho,..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 164.92% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH) is a compelling name in the healthcare sector, particularly in the health information services industry. Specializing in specialty care management services..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential and Investor Insights

NeoGenomics, Inc. (NYSE: NEO) is carving a significant niche in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.59..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 25.91% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) stands out in the healthcare sector, particularly within the medical care facilities industry, with its robust growth trajectory and a..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 60.79% Potential Upside

For investors seeking opportunities in the healthcare sector, Astrana Health Inc. (ASTH) presents a compelling case with its considerable potential upside of 60.79%. As a healthcare..

Arcellx, Inc. (ACLX) Stock Analysis: Unveiling A 61.73% Potential Upside in Biotechnology

Arcellx, Inc. (NASDAQ: ACLX) stands out in the biotechnology sector with its innovative approach to immunotherapy, aiming to tackle some of the most challenging cancer forms...

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 45% Potential Upside Awaits Investors

For investors eyeing the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents itself as a promising opportunity with a projected potential upside of 45.3%. Specializing in..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling a 69.88% Upside Potential in the Medical Devices Sector

Alphatec Holdings, Inc. (ATEC), a prominent player in the healthcare sector, specifically in the medical devices industry, is drawing significant attention from investors due to its..

Ardent Health, Inc. (ARDT) Stock Analysis: A 52.11% Potential Upside with a Strong Buy Consensus

Investors looking for opportunities in the healthcare sector might find Ardent Health, Inc. (NYSE: ARDT) an intriguing choice. As a prominent player in the medical care..

Indivior Pharmaceuticals (INDV) Stock Analysis: A 30% Upside Opportunity Amidst Promising Drug Innovations

Indivior Pharmaceuticals, Inc. (INDV), a leading player in the healthcare sector specializing in the development of buprenorphine-based prescription drugs, is capturing investor attention with its robust..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering the 9.51% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is capturing investor attention with its focused approach in the biotechnology sector, specializing in treatments for autoimmune diseases. As of today,..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Offers 27.67% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a leading player in the healthcare sector, is capturing the attention of investors with its innovative approach to fertility and women’s health..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 5.72% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in newborn and maternal-fetal care..

Clover Health Investments, Corp (CLOV): Investor Outlook on a 46.97% Potential Upside

Clover Health Investments, Corp (CLOV) is stirring interest in the healthcare sector, particularly within the healthcare plans industry, where it seeks to revolutionize Medicare Advantage through..

MiMedx Group, Inc. (MDXG) Stock Analysis: Unpacking a 104% Potential Upside for Investors

MiMedx Group, Inc. (NASDAQ: MDXG) stands out as a noteworthy opportunity in the biotechnology sector, offering an impressive potential upside of over 104% according to current..

Belite Bio, Inc (BLTE) Stock Analysis: Strong Buy Ratings and Promising Clinical Pipeline Signal Growth Potential

Belite Bio, Inc (NASDAQ: BLTE) is capturing investor attention with its compelling clinical pipeline and robust market performance. As a clinical-stage biopharmaceutical company, Belite Bio is..

Zai Lab Limited (ZLAB)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds